+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cost effectiveness of hiv screening of pregnant women in hospitals of the paris area france



Cost effectiveness of hiv screening of pregnant women in hospitals of the paris area france



European Journal of Obstetrics & Gynecology & Reproductive Biology 37(1): 25-34



In the context of an epidemiologic multicentric study about perinatal transmission of HIV, screening was systematically proposed to all pregnant women attending nine maternities clinics of the Paris region (France) (n = 7600, between August 1987 and July 1988) at their first prenatal visit. Among them, 2145 had already been tested and 45 were known to be HIV positive. So, 5660 tests were performed during the first 6 months (period 1), and 17 pregnant women were discovered to be positive. The total cost of screening has been estimated between FF. 720,000 and 775,000, resulting in a mean cost per pregnant woman found to be HIV positive of about FF. 42,000 to 45,000. A similar calculation over the following 5 months (period 2) gave a mean cost of between FF. 165,000 and 178,000. Since the women, before being screened, had to answer a short questionnaire about risk factors; cost and effectiveness of a selective screening strategy could be simulated. The preference of systematic to selective enabled the discovery of two HIV positive cases in each period, the marginal cost, i.e., cost per extra pregnant woman found to be HIV positive was thus FF. 303,320 to 327,540 for period 1, and FF. 572,240 to 619,000 for period 2. Although these figures seem high, an estimation of the cost-effectiveness does not allow us to conclude whether it is in society's interest to devote the funds necessary to move away from selective screening towards systematic screening. The quadrupling of the mean cost of identifying an HIV positive pregnant woman during hospital screening, despite a concomitant increase in prevalence in this population, can be explained only by an increase in prenatal screening prescribed by the private practitioner in ambulatory medicine. The evolution in the hospital program of systematic screening of pregnant women in the Paris area clearly shows that an evaluation of a policy of HIV screening amongst pregnant women depths, at least in the French health system, on the different ways in which the ambulatory and hospital sectors complement themselves when trying to cope with the monitoring of women during pregnancy.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 007165562

Download citation: RISBibTeXText


Related references

Cost-effectiveness of HIV screening of pregnant women in hospitals of the Paris area. European Journal of Obstetrics & Gynecology and Reproductive Biology 37(1): 25-33, 1990

Cost-effectiveness of HIV screening of pregnant women in hospitals of the Paris area. The Paris-Tours study group of antenatal transmission of HIV, Group '9 maternites'. European Journal of Obstetrics, Gynecology, and Reproductive Biology 37(1): 25-33, 1990

Cost-effectiveness analysis of HIV screening in pregnant women in hospitals in the Paris region. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction 19(1): 36-42, 1990

Epidemiology of toxoplasmosis among pregnant women in the paris france area. International Journal of Epidemiology 17(3): 595-602, 1988

Systematic prenatal hiv screening in paris france hospital a cost effectiveness analysis. Journal de Gynecologie Obstetrique et biologie de la Reproduction 19(1): 36-42, 1990

Social acceptability of screening for hiv among pregnant women a survey in paris region france. Journal de Gynecologie Obstetrique et biologie de la Reproduction 18(4): 437-443, 1989

Evaluate HIV incidence from serial prevalence data in pregnant women, Paris area, France. ELEVENTH INTERNATIONAL CONFERENCE ON AIDS [Author] Eleventh International Conference on AIDS, Vol One One world: One hope : 252, 1996

Toxoplasmosis screening in pregnant women and new borns in maternity hospitals of lyon france. Molecular & Biochemical Parasitology (SUPPL): 281-282, 1982

Cost-effectiveness of HIV screening for incarcerated pregnant women. Journal of Acquired Immune Deficiency Syndromes 38(2): 163-173, 2005

Cost-Effectiveness Analysis of Screening Syphilis Among Pregnant Women. Value in Health 17(7): A509-A510, 2014

Universal HIV screening of pregnant women in England: Cost effectiveness analysis. BMJ 318(7199): 1656-1660, June 19, 1999

Cost-effectiveness of screening for the factor V Leiden mutation in pregnant women. Lancet 359(9321): 1919-1920, 2002

O2-S4.02 Cost-effectiveness of screening for Chlamydia trachomatis in Dutch pregnant women. Sexually Transmitted Infections 87(Suppl 1): A61-A62, 2011

HIV screening in pregnant women: A systematic review of cost-effectiveness studies. International Journal of Health Planning and Management 33(1): 31-50, 2017

Cost effectiveness in screening of class I HLA antibodies in Thai pregnant women. Southeast Asian Journal of Tropical Medicine and Public Health 24 Suppl 1: 165-166, 1993